PIRS NASDAQ
Pieris Pharmaceuticals, Inc.
1W: -16.7%
1M: -15.5%
3M: -18.1%
1Y: +21.4%
3Y: -94.6%
5Y: -95.2%
$13.60
Last traded 2024-12-13 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$60M
-32.5% ▼
5Y CAGR: -10.7%
Total Liabilities
$32M
+23.2% ▲
5Y CAGR: -15.7%
Shareholders Equity
$28M
-55.3% ▼
5Y CAGR: -2.0%
Cash & Investments
$58M
-30.6% ▼
5Y CAGR: -3.8%
Total Debt
$633K
+0.0% ▲
5Y CAGR: -48.2%
Net Debt
-$57M
+31.4% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $118M | $39M | $17M | $84M | $58M |
| Short-Term Investments | $0 | $21M | $9M | $0 | $0 |
| Cash & ST Investments | $118M | $59M | $26M | $84M | $58M |
| Net Receivables | $3M | $6M | $572K | $358K | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $7M | $8M | $8M | $4M | $1M |
| Total Current Assets | $128M | $73M | $39M | $88M | $59M |
| Property, Plant & Equip. | $23M | $21M | $0 | $0 | $572K |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $3M | $1M | $0 | $0 | $0 |
| Total Non-Current Assets | $26M | $22M | $0 | $0 | $572K |
| Total Assets | $154M | $95M | $39M | $88M | $60M |
| — Liabilities — | |||||
| Accounts Payable | $9M | $4M | $3M | $5M | $5M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $202K |
| Deferred Revenue | $25M | $21M | $0 | $0 | $0 |
| Other Current Liabilities | $12M | $8M | $2M | $7M | $11M |
| Total Current Liabilities | $51M | $37M | $12M | $12M | $11M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $431K |
| Other Non-Current Liab. | $0 | $0 | $0 | $14M | $20M |
| Total Non-Current Liabilities | $52M | $31M | $0 | $14M | $20M |
| Total Liabilities | $103M | $68M | $12M | $26M | $32M |
| — Equity — | |||||
| Common Stock | $72K | $74K | $98K | $11K | $12K |
| Retained Earnings | -$257M | -$290M | -$315M | -$94M | -$135M |
| Accumulated OCI | $829K | -$254K | $28K | $3K | $83K |
| Total Stockholders Equity | $51M | $28M | $27M | $63M | $28M |
| Total Liabilities & Equity | $154M | $95M | $39M | $88M | $60M |
| — Key Metrics — | |||||
| Total Debt | $14M | $13M | $0 | $0 | $633K |
| Net Debt | -$104M | -$26M | -$17M | -$84M | -$57M |
| Total Investments | $0 | $21M | $9M | $0 | $0 |